Form D · Biotechnology
Celixir plc
Stratford Upon Avon, X0 · CIK 0001735135
Offering snapshot reported Mar 21, 2018 · SEC filing
- Reported sold
- $1.5M Offering amount: $3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1M Reported outside-investor minimum
- First sale
- Mar 6, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2018 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-308211
Source: Form D, filed Mar 21, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lee Chapman | Executive |
| Darrin Disley | Director |
| Martin Evans | Director, Executive |
| Chaim Hurvitz | Director |
| Conor Kehoe | Director |
| Fiona Murray | Director |
| Gary Pisano | Director |
| David Preston | Executive |
| A Reginald | Director, Executive |
| Duncan Ribbons | Executive |
| Nigel Scott | Executive |
| Mubasher Sheikh | Director |
| Sabena Sultan | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Celixir House Stratford Upon Avon Business & Tech Park
Stratford Upon Avon, X0, CV37 7GZ
Stratford Upon Avon, X0, CV37 7GZ